Bing-Neel Syndrome: A Case Report and Systematic Review of Clinical Manifestations, Diagnosis, and Treatment Options

Abstract Background Bing-Neel syndrome is an extremely rare neurologic complication of Waldenstrom macroglobulinemia (WM) that was first described in 1936. It is associated with central nervous system infiltration by neoplastic lymphoplasmacytoid and plasma cells with or without cerebrospinal fluid (CSF) hyperglobulinemia. Case Report We report a case of a 69-year-old white man with a 10-year history of WM. He was diagnosed with Bing-Neel syndrome based on magnetic resonance imaging and pathology studies of CSF. In addition, a comprehensive review of the reported cases of Bing-Neel syndrome in the up-to-date English-language literature was performed. Results Our patient underwent successful treatment with cranial radiation and intrathecal chemotherapy. He has been in clinical and pathologic remission for 3 years following the completion of his treatment. Based on our literature review, we also summarize and discuss clinical manifestations, diagnosis, and treatment options for Bing-Neel syndrome. Conclusion Bing-Neel syndrome is a rare and potentially treatable complication of WM. Patients with a history of WM presenting with neurologic symptoms should be evaluated for possible Bing-Neel syndrome. Cranial radiation therapy alone or in combination with intrathecal chemotherapy is more likely to achieve sustainable remission than intrathecal chemotherapy alone.

[1]  E. Weisenberg,et al.  Pathologic quiz case. , 2009, Archives of pathology & laboratory medicine.

[2]  M. Fog,et al.  Reports of a third case of hyperglobulinemia with affection of the central nervous system on a toxi‐infectious basis , 2009 .

[3]  J. Bing,et al.  Two Cases of Hyperglobulinaemia with Affection of the Central Nervous System on a Toxi‐Infectious Basis.1 , 2009 .

[4]  A. Torvik,et al.  Macroglobulinaemia Waldenstrom. A case with haemolytic syndrome and involvement of the nervous system. , 2009, Acta medica Scandinavica.

[5]  N HARBOE,et al.  Another case of hyperglobulinemia and affection of the central nervous system. , 2009, Acta medica Scandinavica.

[6]  G. Leschziner,et al.  Nineteen‐year follow‐up of Waldenström's‐associated neuropathy and Bing–Neel syndrome , 2009, Muscle & nerve.

[7]  L. Villela,et al.  Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma. , 2008, Anti-cancer drugs.

[8]  S. Montoto,et al.  Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia. , 2008, Critical reviews in oncology/hematology.

[9]  S. Kesari,et al.  Imaging of Bing-Neel syndrome , 2008, Neurology.

[10]  J. Lirng,et al.  Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab , 2008, Leukemia & lymphoma.

[11]  Kyung-Hee Lee,et al.  Therapeutic Experience of Bing-Neel Syndrome Associated with Waldenstrom's Macroglobulinemia , 2007, Journal of Korean medical science.

[12]  V. Holthoff,et al.  Nonfluent aphasia in a patient with Waldenstrom’s macroglobulinemia , 2007, Journal of Clinical Neuroscience.

[13]  J. Fridlyand,et al.  Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Trasimeni,et al.  Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma , 2006, Journal of Neuro-Oncology.

[15]  B. Guidet,et al.  ‘Indolent’ Waldenstrom's macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L , 2006, European journal of haematology.

[16]  M. T. Bhatti,et al.  Bilateral sixth nerve paresis in the Bing-Neel syndrome , 2005, Neurology.

[17]  X. Morandi,et al.  Nervous system lymphoid infiltration in Waldenström's macroglobulinemia. A case report , 2003, Journal of Neuro-Oncology.

[18]  K. Aldape,et al.  Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. , 2003, Blood.

[19]  R. Weil,et al.  Pathologic Quiz Case: A Man With Long-Standing Monoclonal Gammopathy and New Onset of Confusion , 2002 .

[20]  C. Garbar,et al.  Primary Central Nervous System Lymphoma with Waldenström’s Macroglobulinaemia , 2002, European Neurology.

[21]  J. Delgado,et al.  Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing‐Neel syndrome: Case report and review of the literature , 2002, American journal of hematology.

[22]  X. Mariette,et al.  Neurolymphomatosis in Waldenström's macroglobulinaemia , 1999, British journal of haematology.

[23]  R. Scully,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1997. A 74-year-old man with progressive cough, dyspnea, and pleural thickening. , 1997, The New England journal of medicine.

[24]  F. Caputi,et al.  Waldenström's macroglobulinemia associated with glioblastoma. A case report. , 1996, Revue neurologique.

[25]  A. Richards.  Response of meningeal Waldenström's macroglobulinemia to 2-chlorodeoxyadenosine. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Y. Ogura,et al.  Intracerebral infiltration by monoclonal plasmacytoid cells in Waldenstrom's macroglobulinemia--case report. , 1995, Neurologia medico-chirurgica.

[27]  R. Cully,et al.  Weekly clinicopathological exercises. , 1990, The New England journal of medicine.

[28]  S. Katakkar,et al.  Treatable meningeal involvement in Waldenström's macroglobulinemia. , 1984, Annals of internal medicine.

[29]  M. Herman,et al.  Leukoencephalopathy in Waldenström's macroglobulinemia. Immunohistochemical and electron microscopic observations. , 1984, Journal of neuropathology and experimental neurology.

[30]  P. Hansotia,et al.  Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenström's macroglobulinemia , 1983, Neurology.

[31]  T. Dutcher,et al.  Histopathology of the Bing‐Nee1 syndrome , 1961, Neurology.

[32]  J. Coe,et al.  Neurologic aspects of Waldenstrom's macroglobulinemia; report of a case. , 1960, Archives of neurology.

[33]  A. Prasad,et al.  Macroglobulinemia secondary to a lymphosarcoma of the brain. , 1960, Archives of internal medicine.

[34]  J. Fahey,et al.  The histopathology of the macroglobulinemia of Waldenström. , 1959, Journal of the National Cancer Institute.

[35]  I. Schmidt-Wolf,et al.  Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab. , 2004, Haematologica.

[36]  H. Yamamoto,et al.  Importance of central nervous system involvement by neoplastic cells in a patient with Waldenström's macroglobulinemia developing neurologic abnormalities. , 1993, Acta haematologica.

[37]  R. Scully,et al.  Case records of the Massachusetts General Hospital. , 1990 .

[38]  O. Vuia,et al.  Cerebral Reticuloplasmacytosis with Hyperglobulinemia , 1972 .